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Edited by Barry HalliwellAbstract In the present study, we demonstrate for the ﬁrst time
that aging increases the levels of ubiquitinated protein in the
spleen, and that dietary restriction (DR) signiﬁcantly reduces
these age-related increases in ubiquitinated protein. Sumoylated
protein, proteasome subunits, and a protein essential for protea-
some biogenesis (POMP1) were also increased with age in the
spleen but were not signiﬁcantly aﬀected by DR. Chymotrypsin-
like proteasome activity was elevated in the aged spleen, and
was not signiﬁcantly altered by DR. Together, these data demon-
strate for the ﬁrst time the multiple eﬀects of aging and DR on
ubiquitination, sumoylation, and the proteasome in the spleen.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Ubiquitin1. Introduction
Aging is known to have eﬀects on multiple cellular processes,
including the modulation of steady state protein dynamics. For
example, the processes of protein synthesis and protein degra-
dation appear to be deleteriously eﬀected by aging in a variety
of tissues [1,2]. Numerous lines of evidence suggest that alter-
ations in the proteome are not only present during aging, but
likely play a direct role in promoting aging and age-related dis-
ease in a variety of tissues [1–6].
The ubiquitin–proteasome system is a principle mediator of
intracellular protein degradation. The proteasome is composed
of multiple subunits, including subunits of the 20S core protea-
some, as well as proteins which comprise the cap-like proteins
of the 26S proteasome [7]. Generation of proteasome com-
plexes requires a variety of cofactors including the protein pro-
teoassemblin, also known as proteasome maturation protein
(POMP1), which facilitate proteasome complex formation
[8–10]. The ubiquitination and sumoylation of proteins is a
mechanism by which selectively proteins are targeted for deg-Abbreviations: AL, ad libitum; DR, dietary restriction; NIA, National
Institute of Aging; POMP, proteasome maturation protein; Sumo,
small ubiquitin-like modiﬁer; Ub, ubiquitin
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maintenance of cellular homeostasis [11,12].
At present dietary restriction (DR) is the only known inter-
vention to consistently and reliably increase mammalian life-
span. In addition to mediating beneﬁcial eﬀects on lifespan,
DR is known to ameliorate the eﬀects of aging on a variety
of organ systems including hepatic, cardiovascular, immune,
and central nervous system [13–17]. At present the cellular
and biochemical basis for each of these beneﬁcial eﬀects of
DR remains unclear.
The spleen plays an important role in the immune system, in
particular serving as an important site for the initiation of
adaptive immune responses [18]. Both aging and DR are
known to aﬀect the function of the spleen [17–23], although
the eﬀects of aging and DR on the ubiquitin–proteasome path-
way in the spleen have not yet been elucidated. In the current
study, we examined the eﬀects of both aging and DR on the
expression of ubiquitin–proteasome related proteins in the
spleen, as well as an analysis of diﬀerent proteasome activities.
Together, these data demonstrate that aging and DR modulate
the levels of multiple components of the ubiquitin–proteasome
system including the levels of proteasome subunits, ubiquiti-
nated protein levels, and sumoylated protein levels. Addition-
ally, we observed that aging selectively modulated proteasome
peptidase activities. The implications of each of these observa-
tions to aging and dietary restriction are discussed.2. Materials and methods
2.1. Materials
In this study, the POMP1/Ump1 (proteasome maturation protein)
antibody (PW9715), 20S proteasome subunits a1, 2, 3, 5, 6 and 7
(C2, C3, C8, C9, i and f) antibody (PW8195) and 20S proteasome
‘core’ (b) subunits antibody (PW8155) were purchase from Biomol
International, LP (Plymouth Meeting, PA, USA). Ub (P4D1) antibody
(sc-8017), SUMO-1 (D-11) antibody (sc-5308), SUMO-2/3 (N-18) anti-
body (sc-26969) were purchased from Santa Cruz Biotech, Inc. (Santa
Cruz, CA, USA). Proteasome Activator Subunit 4 antibody (ab5620)
was purchased from Abcam (Cambridge, MA, USA). The secondary
antibodies peroxidase conjugated goat anti-rabbit IgG (H + L) (111-
035-003) and peroxidase conjugated goat anti-mouse IgG (H + L)
(115-035-003) were purchase from Jackson ImmunoResearch Lab,
Inc. (West Grove, PA, USA). Protease Inhibitor Cocktail (P2714-
1BTL) and all other reagents were obtained from Sigma (St. Louis,
MO, USA).
2.2. Animal studies
Male Helicobacter-free F344/Brown Norway (F344 · BN F1) rats
were obtained from the NIA dietary restriction (DR) colony. The
spleens were manually dissected after killing via CO2 overdose andation of European Biochemical Societies.
Fig. 1. Eﬀects of aging and dietary restriction on the levels of 20S
proteasome components in the spleen. The levels of 20S beta (A) and
20S alpha (B) proteasome subunits were analyzed in the spleen of 3-
month-old AL, 25-month-old AL, and 25-month-old DR rodents. A
representative blot for each analyses is provided, with the molecular
weight markers provided on left hand margin of each blot. The graphs
represent the mean and S.E.M. of the optical density of the
immunoreactivity from six animals in each experimental group.
*P < 0.05 compared to 3-month-old AL animals.
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month-old ad libitum (AL), six 25-month-old AL, and six 25-month-
old DR rodents. These rodents were all utilized as outlined in IACUC
approved protocols.
2.3. Western blot analysis
Western blot analysis was conducted to measure levels of POMP1,
20S proteasome a and b subunits, and measure changes in protein
ubiquitination and sumoylation cause by aging and DR in rat spleen.
Rat spleens were homogenized in the presence of protease inhibitor
cocktail, 15 lg of each spleen protein sample was separated by SDS–
PAGE (BioRad, 7.5% or 10–20% precast gel) and transferred to nitro-
cellulose membrane (Whatman Schleicher & Schuell Protran Nitrocel-
lulose Transfer Membrane, Dassel, Germany). Membranes were then
successively exposed to diﬀerent primary and secondary antibodies be-
fore being developed using Pierce ECL Western Blotting Substrate
(Pierce, Rockford, IL). The resulting bands were digitalized and quan-
tiﬁed using NIH ImageJ software.
2.4. Analysis of proteasome activities
Proteasome activity was analyzed as described previously by our
laboratory [24,25]. Brieﬂy, spleen lysates were incubated with peptides
speciﬁc for the individual proteasome peptidase activities (chymotryp-
sin-like, trypsin-like, post-glutamyl peptidase activities) and after 2 h
the cleavage of the peptides measured and reported as arbitrary ﬂuo-
rescence units. In each analysis, several lysates were incubated with
the proteasome inhibitor MG132 (5 lM) for 30 min prior to the addi-
tion of substrates, to allow for determination of background values.
2.5. Statistical analysis
Statistical signiﬁcance was determined using a t-test, with a mini-
mum P value of <0.05 required for signiﬁcance.3. Results
3.1. Eﬀects of aging and DR on proteasome activity and
expression of proteasome components
Proteasome activity was determined in the lysates of spleens
from male 3-month-old AL, 25-month-old AL, and 25-month-
old DR rodents from the NIA rodent colony. In these studies,
we observed that there were no eﬀects of aging or DR on the
trypsin-like or post-glutamyl peptidase activities of the protea-
some in the spleen (Table 1). Interestingly, aging was observed
to signiﬁcantly increase the chymotrypsin-like activity of the
proteasome in the spleen (Table 1), with DR having no eﬀect
age-related increases in chymotrypsin-like activity of the pro-
teasome. In order to begin to understand the eﬀects of aging
and DR on the expression of 20S proteasome subunits we con-
ducted Western blot analysis on spleens obtained from the 3-
month-old AL, 25-month-old AL, and 25-month-old DR rats.Table 1
Age-related changes in proteasome activities in the spleen
AL DR
3-Month 25-Month 25-Month
Chymotrypsin 107 ± 34 225 ± 60* 236 ± 54*
Trypsin 72 ± 14 89 ± 11 101 ± 19
Post-glutamyl peptidase 251 ± 25 263 ± 23 297 ± 27
All proteasome activities are reported as the mean and S.D. for the
arbitrary ﬂuorescence units following a 2 h analysis of proteasome
peptidase activities in the diﬀerent spleen lysates. Each of the values
have had the background ﬂuorescence subtracted, by incubating
additional spleen lysates with the proteasome inhibitor MG132 (5 lM)
for 30 min prior to the addition of individual ﬂuorogenic substrate. See
Section 2 for details. AL = ad libitum, DR = dietary restriction.
*P < 0.05 compared to 3-month-old AL spleen.Analysis of 20S beta subunits (Fig. 1A) revealed no signiﬁcant
alteration in proteasome subunit expression, while analysis of
20S alpha subunits revealed a signiﬁcant elevation in protea-
some subunit expression (3-fold) in both aged AL and DR
rodents (Fig. 1B).
We next conducted Western blot analysis of POMP1, a pro-
tein necessary for 20S proteasome biogenesis [8–10], and ob-
served that aged AL rodents had signiﬁcantly elevated
(50% elevated) levels of POMP1 as compared to 3-month-
old rodents (Fig. 2). DR did not signiﬁcantly decrease POMP1
levels, though a trend toward lower POMP1 levels was ob-
served in the DR spleen relative to age-matched AL rodents
(Fig. 2). Interestingly, POMP1 immunoreactivity was never
observed in the 17 kDa range in any of our analyses (which
would be predicted based on the molecular weight of POMP1),
but instead was evident as a higher molecular weight com-
plexes, consistent with previous studies which describe POMP1
as preferentially forming higher molecular weight complexes in
HEK293 cells [26].
Lastly, we sought to determine the eﬀect of aging and DR on
the expression of 26S proteasome components. In these stud-
ies, we focused on the expression of PA200, a component of
the 26S proteasome cap-like structures [27]. Western blot anal-
ysis revealed that there was tremendous variability in the levels
of PA200 in young rodents, with a trend towards decreased
levels of PA200 in the spleens of aged AL and DR rodents
(Fig. 3).
3.2. Eﬀects of aging and DR on the levels of ubiquitinated and
sumoylated proteins
In order to understand how the observed alterations in 20S
and 26S proteasome expression relates to the levels of ubiqui-
tinated protein in the spleen, we conducted additional Western
blot analyses. We observed that there was a signiﬁcant eleva-
tion in the levels of ubiquitinated protein in the aged AL ani-
mals (2.7-fold) as compared to young rodents (Fig. 4). DR
Fig. 2. Eﬀects of aging and dietary restriction on the levels of POMP-1
in the spleen. The level of POMP-1 was analyzed in the spleen of 3-
month-old AL, 25-month-old AL, and 25-month-old DR rodents. A
representative blot for the analyses is provided, with the molecular
weight markers provided on left hand margin of the representative
blot. The graph represents the mean and S.E.M. of the optical density
of the immunoreactivity from six animals in each experimental group.
*P < 0.05 compared to 3-month-old AL animals.
Fig. 3. Eﬀects of aging and dietary restriction on the levels of PA200 in
the spleen. The level of PA200 was analyzed in the spleen of 3-month-
old AL, 25-month-old AL, and 25-month-old DR rodents. A
representative blot for the analyses is provided, with the molecular
weight markers provided on left hand margin of the representative
blot. The graph represents the mean and S.E.M. of the optical density
of the immunoreactivity from six animals in each experimental group.
Fig. 4. Eﬀects of aging and dietary restriction on the levels of
ubiquitinated protein in the spleen. The level of ubiquitinated protein
was analyzed in the spleen of 3-month-old AL, 25-month-old AL, and
25-month-old DR rodents. A representative blot for the analyses is
provided. The graph represents the mean and S.E.M. of the optical
density of the immunoreactivity from six animals in each experimental
group. *P < 0.05 compared to 3-month-old AL animals; **P < 0.05
compared to 24-month-old AL animals.
Fig. 5. Eﬀects of aging and dietary restriction on the levels of
sumoylated protein in the spleen. The level of sumo-1 (A) and sumo-2/
3 (B) immunoreactivity were analyzed in the spleen of 3-month-old
AL, 25-month-old AL, and 25-month-old DR rodents. A representa-
tive blot for the analyses is provided. The graphs represent the mean
and S.E.M. of the optical density of the immunoreactivity from six
animals in each experimental group. *P < 0.05 compared to 3-month-
old AL animals.
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in ubiquitinated protein levels (Fig. 4). Similar to ubiquitin
alterations, aging was observed to elevate the levels of sumoy-
lation by sumo-1 in the spleen (Fig. 5A), although DR was not
observed to signiﬁcantly decrease the levels of proteins modi-
ﬁed by sumo-1 (P = 0.08) (Fig. 5A). Analysis of sumo-2/3 lev-
els revealed that there was a trend toward elevations in sumo-
2/3 levels in both aged AL and aged DR rodents as compared
to young rodents (Fig. 5B).4. Discussion
Previous studies from our laboratory and others have dem-
onstrated that during aging most tissues, including mostrodent tissues analyzed thus far, exhibit a progressive decline
in multiple proteasome peptidase activities [1–4]. The current
study for the ﬁrst time demonstrates that unlike most tissues,
the aging rodent spleen does not exhibit a decline in protea-
some peptidase activities, and actually has an elevation in
chymotrypsin-like proteasome activity with age (Table 1).
Interestingly, DR did not have any signiﬁcant eﬀect on the
age-related changes in proteasome peptidase activities, even
though DR has been reported to ameliorate age-related
declines in proteasome function in some tissues [6].
Our studies demonstrate that aging and DR have eﬀects on
the expression levels of multiple proteasome components.
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observed in the aged spleen relative to young rodents. In con-
trast, no signiﬁcant alterations in 20S beta subunits was de-
tected in the aged spleen, with the levels of PA200 trending
towards being decreased in the aged spleen. Taken together,
these data suggest that the eﬀects of aging on proteasome sub-
unit expression in the spleen are subunit speciﬁc. Recent stud-
ies have demonstrated that in viable cells proteasome subunit
expression can be increased in response to multiple stressors
including oxidative stress and inﬂammatory stimuli [28,29].
Presumably, the elevations in proteasome subunit expression
following these stressors serves a direct role in trying to pre-
serve proteasome-mediated protein degradation, and thereby
contribute to cellular homeostasis. Such stressors may poten-
tially contribute to the changes in proteasome subunit expres-
sion observed in the present study, since both oxidative stress
and increased inﬂammation are believed to contribute to the
eﬀects of aging on the diﬀerent tissues. It is also likely that
the elevation in chymotrypsin-like activity observed in the
aging spleen is mediated in part by an elevations in the amount
of proteasome complexes present in the aging spleen.
The signiﬁcant elevation in both 20S alpha and POMP1 in
the aged spleen are consistent with increased levels of 20S pro-
teasome biogenesis potentially occurring during the aging of
the spleen. Such an elevation could perhaps be a response to
help the spleen increase proteasome activity in the face of ele-
vated levels of stressors during aging, and thereby promote cel-
lular homeostasis in the spleen. It is important to note that the
Western blot analysis in the current study, while providing a
useful assessment of proteasome subunit levels, does not allow
for the determination of alterations in the amount or compo-
sition of proteasome complexes, both of which are important
factors in regulating overall proteasome activity. In particular,
our present ﬁndings cannot distinguish between the amount of
proteasome subunits existing as free subunits and proteasome
subunits present in functional 20S or 26S proteasome com-
plexes. Studies are currently underway to determine the eﬀects
of aging on the amount, composition, and speciﬁc activity of
puriﬁed 20S and 26S proteasome complexes in the spleen of
aging and DR rodents.
In the present study, we demonstrate for the ﬁrst time that
aging increases the levels of ubiquitinated protein in the spleen,
and that DR signiﬁcantly reduces the age-related increases in
ubiquitinated protein in the spleen. The elevation in ubiquiti-
nated protein levels during aging presumably is the result of
elevated levels of aberrant proteins (damaged, misfolded),
and not likely due to an impaired ability to degrade proteins
(since proteasome activity is actually elevated in the aging
spleen). Because DR does not alter the levels of 20S protea-
some subunits or POMP1 relative to what is observed in aging
AL rodents, and does not alter age related changes in protea-
some activities, our data suggest that the reduced levels of
ubiquitinated protein in the spleen following DR are not likely
mediated by an increase in proteasome expression. It is likely
that DR suppresses the levels of ubiquitinated protein in the
spleen via reducing the rate of aberrant protein formation,
and therefore makes the spleen a particularly interesting target
to study in future DR related studies.
This study for the ﬁrst time demonstrates that the amount of
sumoylated protein increases with age in the spleen, and that in
contrast to DR mediated eﬀects on the levels of ubiquitinated
protein, age-related increases in sumoylation are not signiﬁ-cantly aﬀected by DR. Because sumoylation is known to have
eﬀects on protein function/localization these data suggests a
new role for sumoylation potentially contributing to altered
protein function in the aging spleen. It is interesting to note
that in immunoprecipitation experimentation, we observed
that at least 1 protein band in the anti-ubiquitin precipitate
exhibited cross-reactivity with our anti-sumo1 antibody (data
not shown). Taken together, these data suggest that while
ubiquitination and sumoylation are highly related post-trans-
lation modiﬁcations, and both are clearly involved in regulat-
ing protein turnover [11,12], they do not appear to be equally
aﬀected by DR in the spleen.
The spleen is the second largest immune organ of the body,
with the ratio of spleen weight to body weight known to not be
signiﬁcantly altered in response to aging [18]. What is known
to be aﬀected by aging is the composition of the cell types with-
in the aging spleen, with lymphocyte number reduced signiﬁ-
cantly in the aging spleen, which is accompanied by a
concomitant increase in reticular cells and macrophages [18].
DR is known to promote selective declines in speciﬁc lympho-
cyte populations [30]. Our data suggest that changes in ubiqui-
tination, sumoylation, proteasome expression, and proteasome
function may result from these changes in the cellular makeup
of the spleen during aging and in response to DR. Identifying
the speciﬁc cells in the spleen which have the most dramatic
alterations in proteasome levels, proteasome function, ubiqui-
tination, and sumoylation during aging and in response to DR
will be crucial to understanding the ultimate contribution of
the observed proteome changes to the function of the spleen.
Regardless, our data demonstrate that both aging and DR
promote multiple alterations in the proteome of the spleen,
and raise the possibility that these speciﬁc modiﬁcations may
ultimately contribute to the eﬀects of aging and DR on the
function of the spleen.
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